Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Draft Provider-Administered Drug Policies .

Acthar Gel, Cortrophin Gel

Berinert

Hizentra, Gammagard Liquid, Gamunex-C, Gammagard Liquid ERC, Gammaked, Hyqvia, Cuvitri, Cutaquig, Xembify

Durolane, Euflexxa, Gel-One, GelSyn-3, GenVisc 850, Hyalgan, Hymovis, Monovisc, Orthovisc, Supartz/Supartz FX, Synojoynt, Synvisc, Synvisc-One, TriVisc, VISCO-3, Triluron, sodium hyaluronate 1%

Alyglo, Bivigam; Flebogamma; Gamunex-C; Gammagard Liquid; Gammagard S/D; Gammagard Liquid ERC; Gammaked; Gammaplex; Octagam; Privigen; Panzyga; Yimmugo

Lupron Depot, Lupron Depot-Ped, Eligard, Fensolvi, Lutrate Depot, Camcevi,  Leuprolide Acetate Depot 

Prolia; Jubbonti; Ospomyv; Stoboclo; Denosumab-dssb; Conexxence; Denosumab-bnht; Xgeva; Wyost; Xbryk; Osenvelt; Bomyntra

Rituxan, Truxima, Ruxience, Riabni

Stelara, Wezlana, Selarsdi, Pyzchiva, Otulfi, Imuldosa, Yesintek, Steqeyma, Ustekinumab-aekn

Synagis® (Palivizumab)

Velcade, Boruzu, Bortezomib

Kalbitor

Cinryze

Firazyr

Ruconest

Neulasta, Fulphila, Udenyca, Ziextenzo, Nyvepria; Fylnetra, Stimufend, Rolvedon, Ryzneuta, Pegfilgrastim-fpgk

Exondys 51

Haegarda

Tremfya

Injectafer